Organización Nacional de Trasplantes, Madrid, Spain.
Transpl Int. 2011 Jul;24(7):676-86. doi: 10.1111/j.1432-2277.2011.01257.x. Epub 2011 Apr 19.
The aim of the present study was to describe the current situation of donation after circulatory death (DCD) in the Council of Europe, through a dedicated survey. Of 27 participating countries, only 10 confirmed any DCD activity, the highest one being described in Belgium, the Netherlands and the United Kingdom (mainly controlled) and France and Spain (mainly uncontrolled). During 2000-2009, as DCD increased, donation after brain death (DBD) decreased about 20% in the three countries with a predominant controlled DCD activity, while DBD had increased in the majority of European countries. The number of organs recovered and transplanted per DCD increased along time, although it remained substantially lower compared with DBD. During 2000-2008, 5004 organs were transplanted from DCD (4261 kidneys, 505 livers, 157 lungs and 81 pancreas). Short-term outcomes of 2343 kidney recipients from controlled versus 649 from uncontrolled DCD were analyzed: primary non function occurred in 5% vs. 6.4% (P = NS) and delayed graft function in 50.2% vs. 75.7% (P < 0.001). In spite of this, 1 year graft survival was 85.9% vs. 88.9% (P = 0.04), respectively. DCD is increasingly accepted in Europe but still limited to a few countries. Controlled DCD might negatively impact DBD activity. The degree of utilization of DCD is lower compared with DBD. Short-term results of DCD are promising with differences between kidney recipients transplanted from controlled versus uncontrolled DCD, an observation to be further analyzed.
本研究旨在通过专门调查,描述欧洲委员会中循环死亡后捐献(DCD)的现状。在 27 个参与国中,只有 10 个国家确认有任何 DCD 活动,其中比利时、荷兰和英国(主要为控制性)以及法国和西班牙(主要为非控制性)的 DCD 活动最为活跃。在 2000-2009 年间,随着 DCD 的增加,在三个以控制性 DCD 活动为主的国家中,脑死亡后捐献(DBD)减少了约 20%,而在大多数欧洲国家中,DBD 有所增加。每例 DCD 可回收和移植的器官数量随着时间的推移而增加,尽管与 DBD 相比仍然低得多。在 2000-2008 年间,共有 5004 个器官来自 DCD(4261 个肾脏、505 个肝脏、157 个肺和 81 个胰腺)。分析了 2343 例来自控制性 DCD 和 649 例来自非控制性 DCD 的肾移植受者的短期结果:原发性无功能的发生率分别为 5%和 6.4%(P = NS),延迟移植物功能的发生率分别为 50.2%和 75.7%(P < 0.001)。尽管如此,1 年移植物存活率分别为 85.9%和 88.9%(P = 0.04)。DCD 在欧洲越来越被接受,但仍仅限于少数几个国家。控制性 DCD 可能会对 DBD 活动产生负面影响。与 DBD 相比,DCD 的利用率较低。DCD 的短期结果令人鼓舞,来自控制性与非控制性 DCD 的肾移植受者之间存在差异,需要进一步分析。